Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma (Frontiers in Immunology, (2025), 16, (1517387), 10.3389/fimmu.2025.1517387)

In the published article, there was an error in the Funding statement. The original funding statement is as follows: “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIT) (2017R1A2B4008178). Additionally, this research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HA15C0007).” The correct Funding statement appears below. “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIT) (2017R1A2B4008178, 2022R1F1A1075238). Additionally, this research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HA15C0007).” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.